BIGBEAR
PHARMACEUTICAL
Abemaciclib is a kinase inhibitor that exerts its therapeutic effect by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6).
AuthenticGuaranteeFast DeliveryPrivacy FDA Approval AnnouncementSeptember 28, 2017 -- The U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients wit···【More】
Update: 06 Mar,2026Source: BigbearViews: 97
FDA Approval AnnouncementINDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) ···【More】
Update: 06 Mar,2026Source: BigbearViews: 95
FDA Approval AnnouncementINDIANAPOLIS, Oct. 13, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Verz···【More】
Update: 06 Mar,2026Source: BigbearViews: 92
FDA Approval AnnouncementINDIANAPOLIS, March 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Adm···【More】
Update: 06 Mar,2026Source: BigbearViews: 90
Study AnnouncementTHURSDAY, Oct. 23, 2025 -- A study published online Oct. 17 in the Annals of Oncology (coinciding with the annual meeting of the Eur···【More】
Update: 06 Mar,2026Source: BigbearViews: 88
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
